Cargando…
Novel Pharmaceutical Strategy for Selective Abrogation of TSP1-Induced Vascular Dysfunction by Decoy Recombinant CD47 Soluble Receptor in Prophylaxis and Treatment Models
Elevated thrombospondin 1 (TSP1) is a prevalent factor, via cognate receptor CD47, in the pathogenesis of cardiovascular conditions, including ischemia-reperfusion injury (IRI) and pulmonary arterial hypertension (PAH). Moreover, TSP1/CD47 interaction has been found to be associated with platelet hy...
Autores principales: | Yao, Molly, Sturdivant, Jalicia, Ebrahimi, Aren, Ganguly, Samayita, Elbayoumi, Tamer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228143/ https://www.ncbi.nlm.nih.gov/pubmed/34205047 http://dx.doi.org/10.3390/biomedicines9060642 |
Ejemplares similares
-
Efficient Ex Vivo Screening of Agents Targeting Thrombospondin1-Induced Vascular Dysfunction Using a Digital Multiwire Myograph System
por: Yao, Molly, et al.
Publicado: (2021) -
Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment
por: Guillon, Jordan, et al.
Publicado: (2019) -
The TSP1-CD47-SIRPα interactome: an immune triangle for the checkpoint era
por: Montero, Enrique, et al.
Publicado: (2023) -
CD47-Independent Effects Mediated by the TSP-Derived 4N1K Peptide
por: Leclair, Pascal, et al.
Publicado: (2014) -
Anti-tumor activity of a recombinant soluble Fzd7 decoy receptor in human gastric and colon cancer cells
por: Hafezi, Nasim, et al.
Publicado: (2022)